Acute hepatic porphyria (AHP) refers to a family of rare genetic diseases that affect the production of heme, a component of red blood cells. It can cause life threatening complications. AHP can cause ...
Acute Hepatic Porphyria (AHP) is a group of rare genetic liver disorders that can cause severe, life threatening attacks and long-term health issues that require monitoring. Treatment for AHP focuses ...
Mattias Lissing from the Gastroenterology and Rheumatology Unit, at the Department of Medicine, Huddinge (MedH) is defending his thesis: "Liver transplantation, cancer risk and comorbidity in acute ...
During the treatment phase, the effects of placebo or givosiran on the number and frequency of porphyria attacks, as well as on the levels of ALA and PBG, were measured prospectively in a blinded ...
MISSISSAUGA, ON, Dec. 23, 2024 /CNW/ - Alnylam Canada ULC is pleased to announce that GIVLAARI® (givosiran injection) is now funded across Canada through both public and private insurance plans for ...
Acute intermittent porphyria (AIP) is an inborn error of metabolism inherited via a fully identified autosomal dominant gene. The porphyrias, a group of diseases ...
The Center for Applied Medical Research (CIMA) from the University of Navarra and the Amsterdam Molecular Therapeutics BV (AMT) have demonstrated the pre-clinical effectiveness of a treatment against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results